Weight loss jabs may offer a protective effect against dementia and stroke, according to a new study.People with type 2 diabetes and obesity who are taking the drugs are also less likely to die ...

Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.

For people who are obese and have type 2 diabetes, using Ozempic and other GLP-1 agonist drugs cuts the all-cause mortality rate by 30%, according to a new Use of GLP-1 agonists also cut the risk that ...

Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...

A new study of 60,000 people around the world is shedding light on the possible brain health benefits of popular weight-loss ...

Weight loss jabs such as Wegovy and Mounjaro may offer a protective effect against dementia and stroke, according to a new study.

A new study found weight loss injections may help reduce the risk of dementia and stroke in people who are obese and have ...

Recently, research results have been announced that GLP-1 (glucagon-like peptide) receptor agonist drugs have a positive ...

Over seven years, those taking medication such as Ozempic and Mounjaro - were less likely to develop these brain issues or die prematurely. But Edinburgh University's Professor Tara Spires-Jones told ...

Researchers say findings indicate the drugs offer neuroprotective benefits beyond glucose control and weight loss. Experts say it’s a link that needs further study. Doctors have found a way to ...

Men were three times more likely than women to say GLP-1s boosted their confidence and two times more likely to say they were going on more dates. They also reported higher libido, more matches and ...

A new study of more than 1.2 million people found no link between aluminum in childhood vaccines and long-term health ...